Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45K Buy
39
+7
+22% +$487 ﹤0.01% 746
2025
Q4
$2.12K Buy
32
+28
+700% +$1.81K ﹤0.01% 747
2025
Q3
$269 Sell
4
-37
-90% -$2.93K ﹤0.01% 797
2025
Q2
$3.58K Sell
41
-7
-15% -$549 ﹤0.01% 572
2025
Q1
$3.28K Buy
+48
New +$3.92K ﹤0.01% 571

Other funds holding DXCM

High Note Wealth's DXCM Position: Q1 2026 in Review

High Note Wealth increased its DexCom (DXCM) stake by 22% in Q1 2026, buying an estimated $487 and bringing the position to 39 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

High Note Wealth first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.58K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • High Note Wealth held 39 shares of DexCom worth $2.45K as of Q1 2026.
  • High Note Wealth bought 7 DexCom shares in Q1 2026, an estimated $487.
  • DexCom made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #746 holding.
  • High Note Wealth first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
  • High Note Wealth's DexCom position peaked at $3.58K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.